Literature DB >> 12370359

Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection.

Khuong B Nguyen1, Thais P Salazar-Mather, Marc Y Dalod, Jeffrey B Van Deusen, Xiao-qing Wei, Foo Y Liew, Michael A Caligiuri, Joan E Durbin, Christine A Biron.   

Abstract

NK cell cytotoxicity, IFN-gamma expression, proliferation, and accumulation are rapidly induced after murine CMV infections. Under these conditions, the responses were shown to be elicited in overlapping populations. Nevertheless, there were distinct signaling molecule requirements for induction of functions within the subsets. IL-12/STAT4 was critical for NK cell IFN-gamma expression, whereas IFN-alphabeta/STAT1 were required for induction of cytotoxicity. The accumulation/survival of proliferating NK cells was STAT4-independent but required IFN-alphabeta/STAT1 induction of IL-15. Taken together, the results define the coordinated interactions between the cytokines IFN-alphabeta, IL-12, and IL-15 for activation of protective NK cell responses during viral infections, and emphasize these factors' nonredundant functions under in vivo physiological conditions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12370359     DOI: 10.4049/jimmunol.169.8.4279

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  232 in total

1.  Flt3 permits survival during infection by rendering dendritic cells competent to activate NK cells.

Authors:  Céline Eidenschenk; Karine Crozat; Philippe Krebs; Ramon Arens; Daniel Popkin; Carrie N Arnold; Amanda L Blasius; Chris A Benedict; Eva Marie Y Moresco; Yu Xia; Bruce Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

2.  Type I interferon signals control Theiler's virus infection site, cellular infiltration and T cell stimulation in the CNS.

Authors:  Young-Hee Jin; Wanqiu Hou; Seung Jae Kim; Alyson C Fuller; Bongsu Kang; Gwen Goings; Stephen D Miller; Byung S Kim
Journal:  J Neuroimmunol       Date:  2010-06-09       Impact factor: 3.478

3.  CD28 is not directly involved in the response of human CD3- CD56+ natural killer cells to lipopolysaccharide: a role for T cells.

Authors:  M R Goodier; M Londei
Journal:  Immunology       Date:  2004-04       Impact factor: 7.397

4.  Differential effects of stimulatory factors on natural killer cell activities of young and aged mice.

Authors:  Shoko Nogusa; Donna M Murasko; Elizabeth M Gardner
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-27       Impact factor: 6.053

Review 5.  Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything.

Authors:  A Loewendorf; C A Benedict
Journal:  J Intern Med       Date:  2010-05       Impact factor: 8.989

Review 6.  Combination strategies to enhance antitumor ADCC.

Authors:  Holbrook E Kohrt; Roch Houot; Aurélien Marabelle; Hearn Jay Cho; Keren Osman; Matthew Goldstein; Ronald Levy; Joshua Brody
Journal:  Immunotherapy       Date:  2012-05       Impact factor: 4.196

7.  Inflammatory IL-15 is required for optimal memory T cell responses.

Authors:  Martin J Richer; Lecia L Pewe; Lisa S Hancox; Stacey M Hartwig; Steven M Varga; John T Harty
Journal:  J Clin Invest       Date:  2015-08-04       Impact factor: 14.808

8.  Galectins regulate the inflammatory response in airway epithelial cells exposed to microbial neuraminidase by modulating the expression of SOCS1 and RIG1.

Authors:  Mihai Nita-Lazar; Aditi Banerjee; Chiguang Feng; Gerardo R Vasta
Journal:  Mol Immunol       Date:  2015-09-06       Impact factor: 4.407

Review 9.  The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use.

Authors:  Pin-Yu Perera; Jack H Lichy; Thomas A Waldmann; Liyanage P Perera
Journal:  Microbes Infect       Date:  2011-10-25       Impact factor: 2.700

10.  The marginating-pulmonary immune compartment in rats: characteristics of continuous inflammation and activated NK cells.

Authors:  Rivka Melamed; Ella Rosenne; Marganit Benish; Yael Goldfarb; Ben Levi; Shamgar Ben-Eliyahu
Journal:  J Immunother       Date:  2010-01       Impact factor: 4.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.